PMID- 21864356 OWN - NLM STAT- MEDLINE DCOM- 20111219 LR - 20240417 IS - 1749-8090 (Electronic) IS - 1749-8090 (Linking) VI - 6 DP - 2011 Aug 24 TI - A successfully thrombolysed acute inferior myocardial infarction due to type A aortic dissection with lethal consequences: the importance of early cardiac echocardiography. PG - 101 LID - 10.1186/1749-8090-6-101 [doi] AB - Thrombolysis, a standard therapy for ST elevation myocardial infarction (STEMI) in non-PCI-capable hospitals, may be catastrophic for patients with aortic dissection leading to further expansion, rupture and uncontrolled bleeding. Stanford type A aortic dissection, rarely may mimic myocardial infarction. We report a case of a patient with an inferior STEMI thrombolysed with tenecteplase and followed by clinical and electrocardiographic evidence of successful reperfusion, which was found later to be a lethal acute aortic dissection. Prognostic implications of early diagnosis applying transthoracic echocardiography (TTE) are described. FAU - Tsigkas, Grigorios AU - Tsigkas G AD - Department of Cardiology, Patras University School of Medicine, Patras, Greece. FAU - Kasimis, Georgios AU - Kasimis G FAU - Theodoropoulos, Konstantinos AU - Theodoropoulos K FAU - Chouchoulis, Konstantinos AU - Chouchoulis K FAU - Baikoussis, Nikolaos G AU - Baikoussis NG FAU - Apostolakis, Efstratios AU - Apostolakis E FAU - Bousoula, Eleni AU - Bousoula E FAU - Moulias, Athanasios AU - Moulias A FAU - Alexopoulos, Dimitrios AU - Alexopoulos D LA - eng PT - Case Reports PT - Journal Article DEP - 20110824 PL - England TA - J Cardiothorac Surg JT - Journal of cardiothoracic surgery JID - 101265113 RN - 0 (Fibrinolytic Agents) RN - EC 3.4.21.68 (Tissue Plasminogen Activator) RN - WGD229O42W (Tenecteplase) SB - IM MH - Aortic Dissection/*complications MH - Aortic Aneurysm/*complications MH - Echocardiography MH - Female MH - Fibrinolytic Agents/therapeutic use MH - Humans MH - Inferior Wall Myocardial Infarction/diagnostic imaging/*drug therapy/etiology MH - Middle Aged MH - Prognosis MH - Tenecteplase MH - Thrombolytic Therapy MH - Tissue Plasminogen Activator/therapeutic use PMC - PMC3174121 EDAT- 2011/08/26 06:00 MHDA- 2011/12/20 06:00 PMCR- 2011/08/24 CRDT- 2011/08/26 06:00 PHST- 2011/03/27 00:00 [received] PHST- 2011/08/24 00:00 [accepted] PHST- 2011/08/26 06:00 [entrez] PHST- 2011/08/26 06:00 [pubmed] PHST- 2011/12/20 06:00 [medline] PHST- 2011/08/24 00:00 [pmc-release] AID - 1749-8090-6-101 [pii] AID - 10.1186/1749-8090-6-101 [doi] PST - epublish SO - J Cardiothorac Surg. 2011 Aug 24;6:101. doi: 10.1186/1749-8090-6-101.